| Ident. | Authors (with country if any) | Title |
|---|
| 000116 |
Stephen J. Kish [Canada] ; Isabelle Boileau [Canada] ; Russell C. Callaghan [Canada] ; Junchao Tong [Canada] | Brain dopamine neurone 'damage': methamphetamine users vs. Parkinson's disease - a critical assessment of the evidence. |
| 000470 |
Doris E. Payer [Canada] ; Mark Guttman ; Stephen J. Kish ; Junchao Tong ; Antonio Strafella ; Martin Zack ; John R. Adams ; Pablo Rusjan ; Sylvain Houle ; Yoshiaki Furukawa ; Alan A. Wilson ; Isabelle Boileau | [¹¹C]-(+)-PHNO PET imaging of dopamine D(2/3) receptors in Parkinson's disease with impulse control disorders. |
| 000595 |
Yoshiaki Furukawa [Japon] ; Stephen J. Kish [Canada] | Parkinsonism in GTP cyclohydrolase 1-deficient DOPA-responsive dystonia. |
| 000658 |
Junchao Tong [Canada] ; Lee-Cyn Ang [Canada] ; Belinda Williams [Canada] ; Yoshiaki Furukawa [Japon] ; Paul Fitzmaurice [Nouvelle-Zélande] ; Mark Guttman [Canada] ; Isabelle Boileau [Canada] ; Oleh Hornykiewicz [Autriche] ; Stephen J. Kish [Canada] | Low Levels of Astroglial Markers in Parkinson's Disease: Relationship to α-Synuclein Accumulation |
| 000F22 |
Isabelle Boileau [Canada, Niger] ; Doris Payer [Canada] ; Bindiya Chugani [Canada] ; Daniela Lobo [Canada] ; Arian Behzadi [Canada] ; Pablo M. Rusjan [Canada] ; Sylvain Houle [Canada] ; Alan A. Wilson [Canada] ; Jerry Warsh [Canada] ; Stephen J. Kish [Canada] ; Martin Zack [Canada] | The D2/3 dopamine receptor in pathological gambling: a positron emission tomography study with [11C]‐(+)‐propyl‐hexahydro‐naphtho‐oxazin and [11C]raclopride |
| 001104 |
Amandeep Mann [Canada] ; Sharon L. Miksys ; Andrea Gaedigk ; Stephen J. Kish ; Deborah C. Mash ; Rachel F. Tyndale | The neuroprotective enzyme CYP2D6 increases in the brain with age and is lower in Parkinson's disease patients. |
| 001206 |
Russell C. Callaghan [Canada] ; James K. Cunningham ; Jenna Sykes ; Stephen J. Kish | Increased risk of Parkinson's disease in individuals hospitalized with conditions related to the use of methamphetamine or other amphetamine-type drugs. |
| 001354 |
Christian Pifl [Autriche] ; Stephen J. Kish [Canada] ; Oleh Hornykiewicz [Autriche] | Thalamic noradrenaline in Parkinson's disease: Deficits suggest role in motor and non‐motor symptoms |
| 001515 |
Russell C. Callaghan [Canada] ; James K. Cunningham [États-Unis] ; Jenna Sykes [Canada] ; Stephen J. Kish [Canada] | Increased risk of Parkinson's disease in individuals hospitalized with conditions related to the use of methamphetamine or other amphetamine-type drugs |
| 001537 |
Julia Sacher [Canada, Allemagne] ; Eugenii A. Rabiner [Canada] ; Michael Clark [Canada] ; Pablo Rusjan [Canada] ; Alexandra Soliman [Canada] ; Rada Boskovic [Canada] ; Stephen J. Kish [Canada] ; Alan A. Wilson [Canada] ; Sylvain Houle [Canada] ; Jeffrey H. Meyer [Canada] | Dynamic, adaptive changes in MAO-A binding after alterations in substrate availability: an in vivo [11C]-harmine positron emission tomography study |
| 001680 |
Julia Sacher [Canada, Allemagne] ; Eugenii A. Rabiner [Canada] ; Michael Clark [Canada] ; Pablo Rusjan [Canada] ; Alexandra Soliman [Canada] ; Rada Boskovic [Canada] ; Stephen J. Kish [Canada] ; Alan A. Wilson [Canada] ; Sylvain Houle [Canada] ; Jeffrey H. Meyer [Canada] | Dynamic, adaptive changes in MAO-A binding after alterations in substrate availability: an in vivo [11C]-harmine positron emission tomography study |
| 001685 |
Junchao Tong [Canada] ; Isabelle Boileau [Canada] ; Yoshiaki Furukawa [Japon] ; Li-Jan Chang [Canada] ; Alan A. Wilson [Canada] ; Sylvain Houle [Canada] ; Stephen J. Kish [Canada] | Distribution of vesicular monoamine transporter 2 protein in human brain: implications for brain imaging studies |
| 001A40 |
Junchao Tong [Canada] ; Yoshiaki Furukawa [Canada, Japon] ; Allan Sherwin [Canada] ; Oleh Hornykiewicz [Autriche] ; Stephen J. Kish [Canada] | HETEROGENEOUS INTRASTRIATAL PATTERN OF PROTEINS REGULATING AXON GROWTH IN NORMAL ADULT HUMAN BRAIN |
| 001B39 |
Junchao Tong [Canada] ; Henry Wong [Canada] ; Mark Guttman [Canada] ; Lee C. Ang [Canada] ; Lysia S. Forno [États-Unis] ; Mitsunobu Shimadzu [Japon] ; Ali H. Rajput [Canada] ; Manfred D. Muenter [États-Unis] ; Stephen J. Kish [Canada] ; Oleh Hornykiewicz [Autriche] ; Yoshiaki Furukawa [Canada, Japon] | Brain -synuclein accumulation in multiple system atrophy, Parkinson's disease and progressive supranuclear palsy: a comparative investigation |
| 001C10 |
Russell C. Callaghan [Canada] ; James K. Cunningham [États-Unis] ; Gautam Sajeev [Canada] ; Stephen J. Kish [Canada] | Incidence of Parkinson's disease among hospital patients with methamphetamine‐use disorders |
| 001D28 |
Stephen J. Kish [Canada] ; Jason Lerch [Canada] ; Yoshiaki Furukawa [Canada, Japon] ; Junchao Ton [Canada] ; Tina Mccluskey [Canada] ; Diana Wilkins [États-Unis] ; Sylvain Houle [Canada] ; Jeffrey Meyer [Canada] ; Emanuela Mundo [Italie] ; Alan A. Wilson [Canada] ; Pablo M. Rusjan [Canada] ; Jean A. Saint-Cyr [Canada] ; Mark Guttman [Canada] ; D. Louis Collins [Canada] ; Colin Shapiro [Canada] ; Jerry J. Warsh [Canada] ; Isabelle Boileau [Canada] | Decreased cerebral cortical serotonin transporter binding in ecstasy users: a positron emission tomography/[11C]DASB and structural brain imaging study |
| 001D37 |
JUNCHAO TONG [Canada] ; Henry Wong [Canada] ; Mark Guttman [Canada] ; Lee C. Ang [Canada] ; Lysia S. Forno [États-Unis] ; Mitsunobu Shimadzu [Japon] ; Ali H. Rajput [Canada] ; Manfred D. Muenter [États-Unis] ; Stephen J. Kish [Canada] ; Oleh Hornykiewicz [Autriche] ; Yoshiaki Furukawa [Canada, Japon] | Brain α-synuclein accumulation in multiple system atrophy, Parkinson's disease and progressive supranuclear palsy: a comparative investigation |
| 001F26 |
Isabelle Boileau [Canada, Niger] ; Mark Guttman [Canada] ; Pablo Rusjan [Canada] ; John R. Adams [Canada] ; Sylvain Houle [Canada] ; Junchao Tong [Canada] ; Oleh Hornykiewicz [Autriche] ; Yoshiaki Furukawa [Canada] ; Alan A. Wilson [Canada] ; Shitij Kapur [Canada] ; Stephen J. Kish [Canada] | Decreased binding of the D3 dopamine receptor-preferring ligand [11C]-(+)-PHNO in drug-naïve Parkinson's disease |
| 002179 |
Isabelle Boileau [Canada] ; Pablo Rusjan ; Sylvain Houle ; Diana Wilkins ; Junchao Tong ; Peter Selby ; Mark Guttman ; Jean A. Saint-Cyr ; Alan A. Wilson ; Stephen J. Kish | Increased vesicular monoamine transporter binding during early abstinence in human methamphetamine users: Is VMAT2 a stable dopamine neuron biomarker? |
| 002238 |
Stephen J. Kish [Canada, Niger] ; Junchao Tong [Canada] ; Oleh Hornykiewicz [Canada] ; Ali Rajput [Canada] ; Li-Jan Chang [Canada] ; Mark Guttman [Canada] ; Yoshiaki Furukawa [Canada] | Preferential loss of serotonin markers in caudate versus putamen in Parkinson's disease |
| 002329 |
Isabelle Boileau [Canada] ; Jerry J. Warsh [Canada] ; Mark Guttman [Canada] ; Jean A. Saint-Cyr [Canada] ; Tina Mccluskey [Canada] ; Pablo Rusjan [Canada] ; Sylvain Houle [Canada] ; Alan A. Wilson [Canada] ; Jeffrey H. Meyer [Canada] ; Stephen J. Kish [Canada] | Elevated serotonin transporter binding in depressed patients with Parkinson's disease: A preliminary PET study with [11C]DASB |
| 002737 |
Junchao Tong [Canada] ; Oleh Hornykiewicz ; Stephen J. Kish | Inverse relationship between brain noradrenaline level and dopamine loss in Parkinson disease: a possible neuroprotective role for noradrenaline. |
| 002920 |
JUNCHAO TONG [Canada] ; Oleh Hornykiewicz [Autriche] ; Stephen J. Kish [Canada] | Inverse relationship between brain noradrenaline level and dopamine loss in parkinson disease : A possible neuroprotective role for noradrenaline |
| 002B99 |
Yoshiaki Furukawa [Canada] ; James J. Filiano ; Stephen J. Kish | Amantadine for levodopa-induced choreic dyskinesia in compound heterozygotes for GCH1 mutations. |
| 002C84 |
Junchao Tong [Canada] ; Paul S. Fitzmaurice ; Lee Cyn Ang [Royaume-Uni] ; Yoshiaki Furukawa [Canada] ; Mark Guttman ; Stephen J. Kish | Brain dopamine‐stimulated adenylyl cyclase activity in Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy |
| 002D90 |
Mark Guttman [Canada] ; Stephen J. Kish ; Yoshiaki Furukawa | Current concepts in the diagnosis and management of Parkinson's disease. |
| 002E43 |
Paul S. Fitzmaurice [Canada] ; Lee Ang [Canada] ; Mark Guttman [Canada] ; Ali H. Rajput [Canada] ; Yoshiaki Furukawa [Canada] ; Stephen J. Kish [Canada] | Nigral glutathione deficiency is not specific for idiopathic Parkinson's disease |
| 002F12 |
Sophie Vigouroux [France] ; Yoshiaki Furukawa [Canada] ; Luc Farout [France] ; Stephen J. Kish [Canada] ; Marièle Briand [France] ; Yves Briand [France] | Peptidase activities of the 20/26S proteasome and a novel protease in human brain |
| 002F50 |
Stephen J. Kish [Canada] | Biochemistry of Parkinson's disease: Is a brain serotonergic deficiency a characteristic of idiopathic Parkinson's disease? |
| 003035 |
Yoshiaki Furukawa [Canada] ; Gregory Kapatos [États-Unis] ; John W. Haycock [États-Unis] ; Julian Worsley [Canada] ; Henry Wong [Canada] ; Stephen J. Kish [Canada] ; Torbjoern G. Nygaard [États-Unis] | Brain biopterin and tyrosine hydroxylase in asymptomatic dopa‐responsive dystonia |
| 003099 |
Yoshiaki Furukawa [Canada] ; Sophie Vigouroux [France] ; Henry Wong [Canada] ; Mark Guttman [Canada] ; Ali H. Rajput [Canada] ; LEE ANG [Canada] ; Marièle Briand [France] ; Stephen J. Kish [Canada] ; Yves Briand [France] | Brain proteasomal function in sporadic Parkinson's disease and related disorders |
| 003511 |
Yoshiaki Furukawa [Canada] ; Mark Guttman [Canada] ; Steven P. Sparagana [États-Unis] ; Joel M. Trugman [États-Unis] ; Keith Hyland [États-Unis] ; Philip Wyatt [Canada] ; Anthony E. Lang [Canada] ; Guy A. Rouleau [Canada] ; Mitsunobu Shimadzu [Japon] ; Stephen J. Kish [Canada] | Dopa‐responsive dystonia due to a large deletion in the GTP cyclohydrolase I gene |
| 003978 |
Kelly Macmillan Muenter [États-Unis] ; Lysia S. Forno [États-Unis] ; Oleh Hornykiewicz [Autriche] ; Stephen J. Kish [Canada] ; Demetrius M. Maraganore [États-Unis] ; Richard J. Caselli [États-Unis] ; Haruo Okazaki [États-Unis] ; Frank M. Howard Jr. [États-Unis] ; Barry J. Snow [Nouvelle-Zélande] ; Donald B. Calne [Canada] | Hereditary form of parkinsonism—dementia |
| 003986 |
Yoshiaki Furukawa [Canada] ; Stephen J. Kish [Canada] ; E. Martina Bebin [États-Unis] ; Richard D. Jacobson [États-Unis] ; Julie S. Fryburg [États-Unis] ; Willam G. Wilson [États-Unis] ; Mitsunobu Shimadzu [Japon] ; Keith Hyland [États-Unis] ; Keith Trugman [États-Unis] | Dystonia with motor delay in compound heterozygotes for GTP‐cyclohydrolase I gene mutations |
| 003E41 |
Michel P. Furukawa [Japon, Canada] ; Mitsunobu Shimadzu [Japon] ; Ali H. Rajput [Canada] ; Yumiko Shimuzu [Japon] ; Tetsuzo Tagawa [Japon] ; Hideo Mori [Japon] ; Masayuki Yokochi [Japon] ; Hirotaro Narabayashi [Japon] ; Oleh Hornykiewicz [Autriche] ; Yoshikuni Mizuno [Japon] ; Stephen J. Kish [Canada] | GTP‐cyclohydrolase I gene mutations in hereditary progressive and dopa‐responsive dystonia |
| 004C30 |
Douglas S. Gilbert [Canada] ; Stephen J. Kish [Canada] ; Li-Jan Chang [Canada] ; Caryl Morito [Canada] ; Kathleen Shannak [Canada] ; Oleh Hornykiewicz [Canada, Autriche] | Dementia, parkinsonism, and motor neuron disease: Neurochemical and neuropathological correlates |
| 004D50 |
Thomas L. Perry [Canada] ; Voon Wee Yong [Canada] ; William J. Godolphin [Canada] ; Michelle Sutter [Canada] ; Shirley Hansen [Canada] ; Stephen J. Kish [Canada] ; James G. Foulks [Canada] ; Masatoshi Ito [Canada] | Inability to produce a model of dialysis encephalopathy in the rat by aluminum administration |
| 004F36 |
Stephen J. Kish [Canada] ; Caryl Morito [Canada] ; Oleh Hornykiewicz [Canada] | Glutathione peroxidase activity in Parkinson's disease brain |
